The clinical nutrition for diabetes care market has seen considerable growth due to a variety of factors.
• The clinical nutrition for diabetes care market has shown strong growth in recent years. It will rise from $2.93 billion in 2024 to $3.18 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%.
This growth can be attributed to medical professional advocacy, the rise in lifestyle diseases, increased consumer awareness, the development of healthcare infrastructure, and the growing prevalence of diabetes.
The clinical nutrition for diabetes care market is expected to maintain its strong growth trajectory in upcoming years.
• The clinical nutrition for diabetes care market is projected to reach $4.32 billion by 2029 at an 8.0% CAGR. Growth is driven by insurance coverage, the obesity epidemic, and the aging population. Trends include immune-supportive nutrition, plant-based nutrition, functional foods, and digital health integration.
The increase in diabetes prevalence is expected to boost the clinical nutrition for diabetes care market. The growing diabetes rates, driven by sedentary lifestyles and poor diets, are leading to higher demand for tailored nutrition plans that regulate blood sugar and promote overall health. The International Diabetes Federation reported that 537 million adults had diabetes in 2022, with projections to rise to 643 million by 2030.
The clinical nutrition for diabetes care market covered in this report is segmented –
1) By Product: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
2) By Stage: Adult, Pediatric
3) By Sales Channel: Online, Retail, Institutional Sales
Subsegments:
1) By Oral Nutrition: Oral Nutritional Supplements (ONS), Diabetic-Specific Oral Nutritional Drinks, Protein-Rich Oral Supplements, Carbohydrate-Controlled Oral Supplements, Fiber-Enriched Oral Nutrition
2) By Parenteral Nutrition: Amino Acid Solutions For Diabetes, Glucose And Electrolyte Solutions, Lipid Emulsions For Parenteral Nutrition, Micronutrient Infusions For Diabetes, Insulin-Infused Parenteral Nutrition
3) By Enteral Feeding Formulas: Standard Enteral Formulas, Diabetic-Specific Enteral Formulas, High-Protein Enteral Feeding Formulas, Low-Carbohydrate Enteral Formulas, Fiber-Enriched Enteral Formulas, Modular Feeding Solutions
In the clinical nutrition for diabetes care market, companies are developing specialized nutritional formulations to meet the dietary needs of diabetes patients. For instance, in March 2024, Abbott Healthcare introduced Ensure Diabetes Care, a supplement designed to support individuals with diabetes. The product is formulated with a low glycemic index, high-quality protein, and essential nutrients to help manage blood sugar levels.
Major companies operating in the clinical nutrition for diabetes care market are:
• Pfizer Inc.
• Bayer AG
• Sanofi-Aventis LLC
• Abbott Laboratories
• Roche Holdings Inc.
• Medtronic plc
• Danone SA
• Eli Lilly and Company
• Amgen Inc.
• Senseonics Holdings Inc.
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• B. Braun Melsungen AG
• Glanbia plc
• Perrigo Company plc
• Dexcom Inc.
• Nestlé Health Science S.A.
• Tandem Diabetes Care
• Nutricia International Private Limited
• MannKind Corp
• Omada Health
• Senseonics Holdings Inc.
• Diasome Pharmaceuticals Inc.
• Zucara Therapeutics Inc.
• Victus Inc.
North America was the largest region in the clinical nutrition for diabetes care market in 2023. The regions covered in the clinical nutrition for diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.